Comparison of the complement fixation test and competitive ELISA for serodiagnosis of Anaplasma marginale infection in experimentally infected steers

Johann F. Coetzee Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011

Search for other papers by Johann F. Coetzee in
Current site
Google Scholar
PubMed
Close
 BVSc, PhD
,
Peggy L. Schmidt Department of Production Medicine and Epidemiology, College of Veterinary Medicine, Western University of Health Sciences, Pomona, CA 91766-1854

Search for other papers by Peggy L. Schmidt in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Michael D. Apley Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011

Search for other papers by Michael D. Apley in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
James B. Reinbold Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506-5606

Search for other papers by James B. Reinbold in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Katherine M. Kocan Department of Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078-2007

Search for other papers by Katherine M. Kocan in
Current site
Google Scholar
PubMed
Close
 PhD

Abstract

Objective—To compare sensitivity of a complement fixation (CF) test and competitive ELISA (cELISA) for detection of Anaplasma marginale in experimentally infected steers.

Animals—40 crossbred (Angus-Simmental) steers.

Procedures—Steers were inoculated with 2.6 × 109 A marginale–infected erythrocytes (day 0). Blood samples were collected on days 9, 13, 20, 28, 34, 41, 61, 96, 126, and 156 days after inoculation. The percentage of parasitized erythrocytes (PPE) was determined by microscopic examination of stained blood films, and sera were evaluated with the CF test and cELISA by use of USDA-approved methods. Sensitivity and agreement (κ statistic) between the 2 methods were determined. Persistent infections were confirmed by inoculation of blood obtained from infected steers into susceptible, splenectomized calves.

Results—9 days after inoculation, sensitivity of the cELISA was 47.5%, whereas the CF test failed to identify seropositive steers. After day 13, sensitivity of the cELISA and CF test was 100% and 20%, respectively. During peak parasitemia (day 20), sensitivity of the cELISA and CF test was 100%. Thereafter, sensitivity of the CF test fluctuated between 7.5% and 37.5%, whereas sensitivity of the cELISA remained at 100%. Overall sensitivity of the cELISA and CF test was 94.8% and 26.5%, respectively (κ statistic, 0.039).

Conclusions and Clinical Relevance—The cELISA had superior sensitivity for serologic detection of A marginale.The CF test and cELISA each had a high percentage of false-negative results during the prepatent period. These findings are relevant for export certification and anaplasmosis prevention or eradication programs.

Abstract

Objective—To compare sensitivity of a complement fixation (CF) test and competitive ELISA (cELISA) for detection of Anaplasma marginale in experimentally infected steers.

Animals—40 crossbred (Angus-Simmental) steers.

Procedures—Steers were inoculated with 2.6 × 109 A marginale–infected erythrocytes (day 0). Blood samples were collected on days 9, 13, 20, 28, 34, 41, 61, 96, 126, and 156 days after inoculation. The percentage of parasitized erythrocytes (PPE) was determined by microscopic examination of stained blood films, and sera were evaluated with the CF test and cELISA by use of USDA-approved methods. Sensitivity and agreement (κ statistic) between the 2 methods were determined. Persistent infections were confirmed by inoculation of blood obtained from infected steers into susceptible, splenectomized calves.

Results—9 days after inoculation, sensitivity of the cELISA was 47.5%, whereas the CF test failed to identify seropositive steers. After day 13, sensitivity of the cELISA and CF test was 100% and 20%, respectively. During peak parasitemia (day 20), sensitivity of the cELISA and CF test was 100%. Thereafter, sensitivity of the CF test fluctuated between 7.5% and 37.5%, whereas sensitivity of the cELISA remained at 100%. Overall sensitivity of the cELISA and CF test was 94.8% and 26.5%, respectively (κ statistic, 0.039).

Conclusions and Clinical Relevance—The cELISA had superior sensitivity for serologic detection of A marginale.The CF test and cELISA each had a high percentage of false-negative results during the prepatent period. These findings are relevant for export certification and anaplasmosis prevention or eradication programs.

Anaplasmosis, caused by the rickettsial hemoparasite Anaplasma marginale, is one of the most prevalent tick-transmitted diseases of livestock throughout the world.1–3 Economic loss to the US livestock industry as a result of anaplasmosis is estimated to be > $300 million per annum.3 Anaplasmosis is currently classified in the OIE Terrestrial Animal Health Code list of notifiable diseases because of its socioeconomic impact and importance in terms of restrictions in the international trade of animals and animal products.4

Cattle that recover from acute anaplasmosis, including those treated with recommended doses of tetracyclines, develop persistent infections that range from 102 to 107 infected erythrocytes characterized by cyclic rickettsemia at intervals of approximately 5 weeks.5–7 Although infected erythrocytes are not always detectable in stained blood films during those cycles, persistently infected cattle serve as reservoirs of infection for mechanical and tick-borne transmission.7–9 Therefore, serologic tests are needed for identification of A marginale–infected cattle during the incubation period and persistent infections.10–12

Historically, the most widely used serologic tests for detecting A marginale infections were the CF and card agglutination tests.12 The USDA CF method is a serum-dilution test based on hemolysis of erythrocytes as a result of fixation of complement. Titers are expressed in relation to the highest dilution of serum that has < 100% hemolysis after addition of antigen. The CF test has a low sensitivity (20%) for identifying persistently infected cattle.11 Although the CF test is still offered by many accredited veterinary diagnostic laboratories, it has been considered unreliable for use in certifying cattle that are free of A marginale for interstate and international movement of animals.12

On the basis of the manufacturer's information,13 a cELISA, the development of which was reported elsewhere,14 has an improved sensitivity of 96% and specificity of 95% when used to identify persistently infected cattle.10 Results are measured in terms of the percentage of inhibition (typically 30%) relative to a standardized positive control sample. To our knowledge, sensitivity of the cELISA during the incubation period of A marginale infections has not been reported. This information is important for identification of infected cattle and certification of infection-free cattle prior to export. The purpose of the study reported here was to compare sensitivity of the CF test and cELISA for detection of antibodies in experimentally infected steers during the prepatent, acute, recovery, and carrier stages.

Materials and Methods

Cattle—Forty healthy crossbred (Angus-Simmental) beef steers (from an initial pool of 46 steers) were enrolled in the study. Cattle used in the study reported here were used in another study15 in which 3 oxytetracycline regimens for the treatment of persistent A marginale infections in beef cattle were tested. Steers were procured from a herd used for teaching and research at Iowa State University and were housed at the Iowa State University Beef Nutrition Farm. Steers were approximately 160 to 230 days old and weighed 214 to 346 kg at the time of the study.

The study was conducted between November 5, 2002, and April 15, 2003, to minimize the risk of vector-borne transmission of A marginale among test cattle. Blood samples were tested for anti–A marginale antibodies by use of a cELISA,10,13 and slides of stained blood films were examined for evidence of anaplasmosis. The PCV of each steer was determined to provide baseline data. The protocol for this study was approved by the Committee on Animal Care at Iowa State University (No. 5-2-5172-B).

Housing and husbandry—Initially, steers were grouped in 8 pens, each of which contained 5 or 6 steers of similar size. Steers were inoculated with an isolate of A marginale and then assigned to randomized treatment groups. Steers were regrouped on the basis of treatment into pens containing 5 steers/pen. Each treatment group of 10 steers was housed in 2 adjacent pens and separated from other treatment groups by an empty pen. Drinking troughs were not shared among treatment groups. Pens were bedded with shredded paper, which was replaced as needed.

Inoculation of steers—An isolate of A marginale derived in 1999 from a cattle herd in Oklahoma16 was used in the study. This isolate has been genotyped and is infective and transmissible by ticks.16,17 Infected blood was prepared as a frozen stabilate with 10% dimethyl sulfoxide and maintained in liquid nitrogen prior to inoculation of a splenectomized calf at Oklahoma State University. Whole blood (350 mL) was collected in sterile syringes coated with heparin from the inoculated calf when the PCV was 34% and PPE was 21.6%. Each test steer was inoculated IV with 1 mL of whole blood containing approximately 2.6 × 109 infected erythrocytes. Day of inoculation was designated as day 0.

Postinoculation monitoring of steers—After inoculation, steers were monitored daily for clinical signs of anaplasmosis, including anorexia and lethargy. Rectal temperature was also measured at selected time points. Blood samples were collected 9, 13, 20, 28, 34, 41, 61, 96, 126, and 156 days after inoculation for determination of PPE and PCV and serologic testing by use of the CF test and cELISA. Blood samples were collected via jugular venipuncture by use of an 18-gauge, 1-inch needle.a To obtain serum, 10-mL sterile glass tubes without additiveb were used, whereas 7-mL glass tubes containing potassium EDTAc were used for collection of blood samples for measurement of PCV and hematologic analysis. Blood in EDTA was refrigerated prior to PCV determination or packaged in insulated material for delivery by overnight courier to Oklahoma State University for determination of the PPE. Serologic testing was conducted at the Iowa State University Veterinary Diagnostic Laboratory.

Examination of blood films and determination of PPE—Blood films for determination of the PPE were stained by use of a 30-second, 3-step staining technique,d which is comparable to the Wright-Giemsa method. Two slides were prepared for each blood sample and examined for A marginale at 1,000X magnification by use of emersion oil and a grid. A total of 500 cells were counted within the 4 squares of the grid, and the number of infected cells was recorded. The PPE was the number of infected cells divided by the total number of cells counted and the quotient multiplied by 100.

Measurement of PCV—The PCV was determined by partially filling heparinized capillary tubese with blood followed by centrifugationf (12,600 × g for 10 minutes). The PCV was then determined by manual measurements of the height of the RBCs and total column height.

cELISA—A commercial cELISA,g which was based on recombinant Anaplasma MSP-5 antigen produced by plasmid-transformed Escherichia coli, was used in accordance with the method described by the OIE12 and recommended by the manufacturer.13 Briefly, 70 ML of undiluted serum was added to each well (wells were coated with MBP) of an adsorption transfer plate that included 2 positive and 3 negative control samples. Adsorption of MBP typically produced by E coli prior to plasmid transformation is required to prevent nonspecific inhibition of conjugate binding, which thereby improves test specificity. Plates were incubated at 20° to 25°C for 30 minutes. Fifty microliters of adsorbed serum was then transferred to antigen-coated plates (plastic wells were coated with MSP-5 Anaplasma antigen). Contents of wells were mixed, and plates were incubated at 20° to 25°C for 60 minutes. After incubation, wells were emptied and washed twice with 200 ML of diluted wash solution. Thereafter, 50 ML of diluted 1X antibody-peroxidase conjugate was added to each well, and plates were incubated at 20° to 25°C for an additional 20 minutes. Plates were then emptied and washed 4 times with 200 ML of diluted wash solution. Fifty microliters of substrate solution was added to each test well. Test samples were again incubated at 20° to 25°C for 20 minutes, which was followed by the addition of a stop solution. Immediately after addition of the stop solution, the OD of each well was measured by use of an ELISA plate reader at a wavelength of 620 nm. Percentage inhibition of each sample was calculated by use of the following equation:

article image

Samples that had inhibition of < 30% were recorded as negative results, whereas samples that had inhibition of ≥ 30% were recorded as positive results.

CF test—The CF test was conducted by use of a microtiter technique described by other investigators18 and detailed in USDA guidelines.19 Briefly, 0.1 mL of serum, a positive control sample, and a negative control sample were diluted 1:5 in veronal buffered diluent and then heat inactivated by incubation at 58°C for 35 minutes. After heat inactivation, 0.025 mL of diluted serum, 0.025 mL of diluted test antigen, and 0.025 mL of diluted complement containing 5.5 CaH50 (ie, 50% hemolytic unit of complement) were added to each well. The hemolytic unit in complement fixation tests is the smallest amount of complement or serum that will produce complete hemolysis of sensitized red cells. Contents of the wells were mixed, and plates were incubated at 37°C for 1 hour. Erythrocytes were sensitized by adding a standardized 2% erythrocyte suspension to an equal volume of optimal hemolysin dilution, which was followed by incubation at 37°C for 10 minutes. Then, 0.05 mL of the sensitized erythrocytes was added to each test well.

Five drops of hemoglobin color standard were added to each well that contained reagent control samples. Plates with these control wells were then shaken and incubated at 37°C for 20 minutes, which was followed by resuspension of cells through shaking and incubation for an additional 25 minutes. Plates were then centrifuged at 300 × g for 5 minutes. Serum antibody titers against A marginale were determined as the reciprocal of the highest dilution at which none of the sensitized erythrocytes was hemolyzed. Partial hemolysis (between 25% and 75%) at the 1:5 dilution was interpreted as a suspect result, whereas hemolysis of ≥ 76% was interpreted as a negative result.

Inoculation of blood into susceptible, splenectomized calves—Inoculation of blood obtained from suspected carrier cattle into splenectomized calves, which are highly susceptible to infection, is considered to be the criterion-referenced test for detection of A marginale infections in cattle. For this test, 46 Holstein calves (6 to 12 weeks old) that weighed between 45 and 112 kg were obtained from a university dairy research facilityh and a commercial calf-rearing facility.i It was known that cattle at each of those facilities had a low prevalence of anaplasmosis. Calves were assessed via clinical examination to ensure that they were healthy, and the cELISA was used to confirm the calves were seronegative and susceptible to infection with A marginale. Calves were then splenectomized to increase their susceptibility to A marginale infection. Splenectomies were performed in accordance with a technique described elsewhere.20

Fifty milliliters of blood was collected from each of the 40 steers in the study into heparinized syringes. Blood from each steer was inoculated IV into splenectomized calves (1 steer for each splenectomized calf). After inoculation, calves were monitored for signs of anaplasmosis by daily observation and weekly determinations of PCV values. Infection with A marginale was confirmed by microscopic examination of stained blood films and measurement of cELISA values. When the PCV of an inoculated calf decreased to < 20%, the calf was euthanatized and necropsied.

Statistical analysis—The PCV data were entered into a software packagej for subsequent calculations and manipulation. Mean ± SEM values were calculated for each time point. A software programk was used to perform statistical analysis. An ANOVA and the Tukey-Kramer honestly significant difference method were used to conduct multiple comparisons among time points after inoculation.

Data sets consisted of results for the 2 diagnostic tests being investigated and the criterion-referenced test. These diagnostic tests were designed to detect the carrier state of A marginale in cattle. Sensitivity estimates for the CF test and cELISA were calculated in a spreadsheet programj by use of the following equation:

article image

Estimates for the 95% CI for sensitivity were calculated by use of the score CI as recommended in another report.21 This method of CI calculation yields nearly uniform probabilities for binomial parameters sampled from a uniform distribution, regardless of sample size, whereas the alternative Wald method typically is anticonservative and varies on the basis of sample size. Specificities for the CF test and cELISA could not be determined as part of the study because all steers were infected with A marginale as part of a larger project.

Agreement between results for the CF test and cELISA was assessed by calculating a κ statistic.22,23 Data were converted to a binary format (0 = no disease and 1 = disease) by use of a cutoff value of 1:5 for the CF test and 30% inhibition for the cELISA test, as described previously. Thereafter, data were compared by contingency analysis by use of a 2 × 2 table in which κ represented the actual agreement between the tests divided by the potential agreement beyond chance in accordance with the following equation:

article image

where A is the number of steers that had positive results for both the CF test and cELISA multiplied by the number of steers that had negative results for both the CF test and cELISA (ie, product of results in agreement), B is the number of steers that had positive results for the CF test and negative results for the cELISA multiplied by the number of steers that had negative results for the CF test and positive results for the cELISA (ie, product of the discordant results), C is the total number of steers with positive results for the CF test multiplied by the total number of steers with negative results for the CF test, and D is the total number of steers with positive results for the cELISA multiplied by the total number of steers with negative results for the cELISA test.

The κ statistic measures the agreement between 2 tests on a scale from 0 to 1. When applied to test results, common interpretations of κ values are that < 0.2 is slight agreement, 0.2 to 0.4 is fair agreement, 0.4 to 0.6 is moderate agreement, 0.6 to 0.8 is substantial agreement, and > 0.8 is almost perfect agreement.23 When the κ statistic could not be determined because of a lack of concordant results in 2 or more 2 × 2 cells, an overall proportion of concordance was calculated by dividing the sum of concordant test results (both the CF test and cELISA with positive results and both the CF test and cELISA with negative results) by the number of samples tested.22

Results

Prior to inoculation, all steers included in the study were seronegative for anaplasmosis (cELISA, < 30% inhibition), and rickettsiae were not detected in stained blood films. Furthermore, the mean PCV for all steers was 38.03% (95% CI, 37.04% to 39.00%), which was within the reference interval for the Hct (24% to 46%).24 All steers in the study became infected with A marginale as confirmed by clinical signs of anaplasmosis and microscopic identification of organisms on stained blood films obtained from inoculated study steers and inoculated splenectomized calves.

All steers in the study had evidence of A marginale–parasitized erythrocytes by day 13 after inoculation, although the overall mean PPE was < 1% (Table 1). Mean PPE reached a peak of 9.17% (95% CI, 7.58% to 10.75%) on day 20, which was accompanied by a significant reduction in PCV (to 27.58%), although this value was still within the reference interval. The highest mean ± SEM body temperature was 39.68 ± 0.17°C, which was recorded on day 24. The lowest mean PCV was measured on day 28 (ie, 8 days after peak PPE), after which the Hct started to increase (Figure 1). However, evidence of anemia associated with Anaplasma infection continued until day 41 as indicated by PCVs that differed significantly from preinoculation values. By day 61, A marginale–infected parasites were not evident in stained blood films, and PCVs had returned to preinoculation values.

Table 1—

Mean and 95% CI values for several variables at various time points after inoculation of 40 beef steers with 2.6 × 109 Anaplasma marginale–infected erythrocytes.

Day after inoculation*cELISACF testAgreement between CF test and cELISA (κ)PPEPCV 
Se (%)95% CI (%)Se (%)95% CI (%)Mean (%)95% CIMean (%)95% CI (%)
947.532.9–62.5000.5250036.35a35.52–37.18
1310091.3–1002010.5–34.80.2000.620.52–0.7135.43a34.60–36.25
2010091.3–10010091.3–1001.0009.177.58–10.7527.58b,c26.62–28.53
2810091.3–10037.524.2–530.3754.312.88–5.7325.40c24.11–26.68
3410091.3–10012.55.5–26.10.1251.010.73–1.2829.43b28.24–30.60
4110091.3–1007.52.5–19.90.0750.550.41–0.6932.35d31.16–33.54
6110091.3–100157.1–29.10.1500035.83a34.97–36.68
9610091.3–10017.58.7–320.17500NRNR
12610091.3–1003018.1–45.40.3000037.48a36.53–38.42
15610091.3–1002514.2–40.20.25000NRNR
Overall94.892.1–96.526.522.4–31.00.039NDNDNDND

Day of inoculation was designated as day 0.

Proportion of concordance analysis.

Se = Sensitivity. NR = Not recorded. ND = Not determined.

Within a column, values with different superscript letters differ significantly (P < 0.05).

Figure 1—
Figure 1—

Mean and 95% CI values for sensitivity of a cELISA (black squares) and a CF test (white diamonds) and the PPE (black triangles) and PCV (crosses) in 40 beef steers after inoculation with 2.6 × 109 Anaplasma marginale–infected erythrocytes. Day of inoculation was designated as day 0.

Citation: American Journal of Veterinary Research 68, 8; 10.2460/ajvr.68.8.872

On day 9, the mean ± SEM inhibition for the cELISA was 24.82 ± 2.86%. Nineteen steers were classified as having positive results by use of the 30% inhibition cutoff value recommended by the OIE and the manufacturer. This provided a calculated test sensitivity of 47.5% (95% CI, 32.9% to 62.5%). In contrast, the CF test failed to identify any steers as having positive results at this time point (Figure 1; Table 1). By day 13, the mean inhibition for the cELISA had increased to 66.84 ± 1.55%. At this time point, all cattle were regarded as having positive results for the cELISA (sensitivity, 100% [95% CI, 91.3% to 100%]) by use of the recommended inhibition cutoff value of 30%, whereas the CF test had a calculated sensitivity of only 20% (95% CI, 10.5% to 34.8%). On day 20, mean value for percentage inhibition for the cELISA had increased to 83.92 ± 0.62%. This coincided with a peak mean PPE of 9 ± 1.57% (range, 3% to 24%). At this time point, all steers had positive results for the CF test (sensitivity of 100%).

After the peak in parasitemia, sensitivity of the CF test fluctuated between 37.5% (95% CI, 24.2% to 53%) on day 28 and 7.5% (95% CI, 2.5% to 19.9%) on day 41, whereas sensitivity of the cELISA remained at 100% (95% CI, 91.3% to 100%) for the remainder of the study. During the period 156 days after inoculation, overall sensitivity for the cELISA was 94.8% (95% CI, 92.1% to 96.5%), whereas overall sensitivity for the CF test was only 26.5% (95% CI, 22.4% to 31.0%).

Agreement between the CF test and cELISA at each of the sampling time points could not be determined by use of the κ statistic because of a lack of concordant results in 2 or more 2 × 2 cells. The overall proportion of concordance at each time point varied from 0.075 on day 41 to 1 on day 20 (Table 1). Mean ± SEM value for the κ statistic that described the overall agreement between the 2 tests during the course of the study was 0.039 ± 0.009.

Discussion

In the study reported here, sensitivity of the CF test and cELISA was compared for detection of A marginale in steers from the time of inoculation through the phase of persistent infection for experimentally induced anaplasmosis. To our knowledge, this is the first report evaluating fluctuations in A marginale test sensitivity at sequential time points after onset of infection. Sensitivity of the cELISA was < 50% during the first 10 days after inoculation. These data are clinically relevant because serologic surveys are often conducted in cattle populations in which recent vector-borne or iatrogenic transmission of A marginale could result in some animals having prepatent infections at the time of sample collection. This study revealed the importance of recognizing limitations of these diagnostic tests when applied to cattle during the early stages of anaplasmosis. This finding has important implications for disease classification prior to interstate or international movement, especially when moving cattle from endemic to nonendemic areas or during seasons of the year when tick and biting flies are prevalent.

Sensitivity of the CF test for A marginale in cattle ranges from 20% with a cutoff value of 1:5 (as was used in the study reported here) to 14% with a cutoff value of 1:10.11,25 Serum samples used to determine sensitivity in those other studies11,25 were collected from naturally infected cattle with unknown infection status or duration of infection. The sensitivity values we reported here were contained within the range of values cited in the literature. However, our study revealed that the CF test failed to detect seropositive cattle up to 2 weeks after inoculation and that sensitivity may be as low as 7.5% after acute infection has passed. Sensitivity value for the cELISA test in another study10 was 96%, which is consistent with the sensitivity reported in our study. The κ statistic of 0.039 determined in our study indicated only slight agreement between the tests on the basis of the classification system described elsewhere.23

Variation in the CF test results in the study reported here concurred with a report of poor performance in a posttreatment study.25 The superior sensitivity of the cELISA versus the CF test at all data collection points after inoculation (except for day 20, on which there was equal sensitivity) indicated that the cELISA should be the preferred test for identification of recently infected or persistently infected cattle. However, caution should be used in the direct extrapolation of this information to cattle naturally infected with A marginale because the infective dose used in this study may have been much higher than the dose that would be inoculated through natural vectors (eg, ticks) or mechanical transmission (eg, biting flies or blood-contaminated fomites).

Despite the high infective dose used in the study reported here, the course and duration of infection we detected was consistent with results of another study26 in which the severity of anaplasmosis was found to be directly related to age, with subclinical infections in cattle < 1 year old.27 The PCVs of the calves used in our study were within the reference range, although a significant decrease in Hct was detected after peak parasitemia. The onset of parasitemia in our study was approximately 13 days. This finding is noticeably shorter than the typical prepatent period of 21 days after natural transmission.28

Other investigators29 found that the time of onset of detectable parasitemia was generally shorter and peak parasitemia was often higher with increasing challenge doses of A marginale. These findings were supported in our study and may have led to bias in the study reported here because the time of onset and extent of antibody response detected may be proportional to the challenge dose. This could have resulted in increases in estimates of sensitivity and a shorter incubation period in which test sensitivity may be questionable. The use of naturally infected calves was not feasible for this study because comparison of the 2 tests necessitated the use of a uniform infective dose and knowledge of the exact time of inoculation and subsequent infection. A follow-up study in which the inoculation doses are comparable to those in vector-borne or fomite-transmitted infection may yield differing results, although to our knowledge, the number of infective organisms transmitted by ticks during the feeding period has not been reported.

Without concurrent calculations for test specificity, the percentage of false-positive results detected by each test could not be determined (ie, 1 – specificity). Because the cost of a false-positive result for a specific animal may be high (exportation restrictions, adverse effects of tetracycline administration, and risk of being culled or euthanatized), variations in test specificity during the natural progression of disease may be as enlightening as the sensitivity results reported here. Specificity data would also be important to determine the ideal or optimum cutoff points for the CF test and cELISA in naturally infected animals.

Microscopic examination of stained blood films is commonly used to detect A marginale organisms in erythrocytes of infected animals. However, this diagnostic technique may be unreliable when cattle have minimal infections or in advanced cases of the disease when animals are severely anemic.28 In the study reported here, the cELISA accurately identified all infected cattle before the number of A marginale–infected erythrocytes exceeded a PPE of 1%. This suggests that the cELISA may be more sensitive than examination of stained blood films for identifying early clinical cases. Furthermore, in instances in which the PPE is low, intraerythrocytic inclusions of A marginale may easily be confused with Howell-Jolly bodies, basophilic stippling of reticulocytes, and stain contamination. This suggests that the cELISA may be a useful alternative to examination of stained blood films for the diagnosis of anaplasmosis, especially in situations in which experience of clinicians or the available facilities are insufficient for interpretation of blood films.

Veterinarians should exercise caution before making a definitive diagnosis of acute anaplasmosis solely on the basis of a positive result for the cELISA and clinical signs such as fever, anemia, and icterus. Anaplasma marginale carrier cattle are cELISA positive but not rickettsemic and therefore do not develop anemia and icterus associated with erythrophagocytosis of parasitized erythrocytes. Differential diagnoses that should be ruled out on the basis of these clinical signs include acute anthrax, leptospirosis, bacillary hemoglobinuria, oak poisoning, poisoning caused by ingestion of Brassica species, multicentric lymphosarcoma, babesiosis, theileriosis, and trypanosomiasis.28 In such circumstances, it would be advisable to detect intraerythrocytic inclusions of A marginale by examination of blood films to assist in differentiating between anaplasmosis and these other diseases.

The cELISA currently used for the diagnosis of anaplasmosis in cattle is based on the use of monoclonal antibody ANAF16C1 that recognizes MSP5 in A marginale, Anaplasma centrale, and Anaplasma ovis.14,30 Analysis of findings suggests that the commercially available MSP5 cELISA13 used in the study reported here may also recognize anti–Anaplasma phagocytophilum antibodies in infected cattle.31 The MSP5 sequence is highly conserved among strains of A marginale as well as between A marginale, A centrale, and A phagocytophilum. Cross-reactivity of the MSP5 test with multiple Anaplasma spp has been confirmed through the identification of common regions defined to be essential for ANAF16C1 reactivity.32 Thus, the MSP5 cELISA most likely does not differentiate Anaplasma spp when there is coinfection with A phagocytophilum and A marginale.33–35

In an unpublished telephone survey of 34 laboratories accredited by the American Association of Veterinary Laboratory Diagnosticians conducted by the authors, it was found that 16 laboratories still offer the CF test as well as the cELISA. Results of the study reported here, in consideration with results of other published reports, suggest that the continued use of the CF test could result in infected cattle being assigned a negative result, which could thus lead to introduction of persistently infected animals with false-negative results into populations of completely naïve cattle. It is estimated36 that the introduction of anaplasmosis into a naïve herd can result in a 3.6% reduction in calf crop, a 30% increase in cull rate, and a 30% mortality rate in clinically infected adult cattle, which can be economically devastating to livestock producers in nonendemic areas.

In addition to the risk of introducing anaplasmosis into naïve herds, movement of infected cattle misclassified as seronegative by use of the CF test into areas in which anaplasmosis is endemic may result in the introduction of new A marginale genotypes. A phylogenetic study37 of A marginale isolates in the United States has revealed that many more genotypes of A marginale exist in nature than have been described. This genetic diversity most likely is attributable to the phenomenon of infection exclusion to A marginale that results in 1 genotype/animal.38,39 Once a new genotype is introduced into a particular region, it will be maintained in ticks and cattle by independent transmission events and will likely become endemic. Persistently infected cattle and ticks could both serve as reservoirs of the introduced genotype. This is important because these diverse A marginale genotypes may not provide cross-protection, thus greatly increasing the challenge to use vaccination as a method for control of anaplasmosis.36 Therefore, correct classification of disease status is essential to restrict movement of infected cattle to prevent diversification of A marginale isolates.

The results reported here support the findings of other studies in which the cELISA has superior sensitivity for detection of anaplasmosis, compared with that for the CF test. However, our study also illustrated the importance of recognizing the limitations of these diagnostic tests when applied to cattle during the early stages of infection. This finding has important implications for disease classification prior to local, interstate, or international movement of cattle and for future disease control and eradication programs. Additional research is necessary to evaluate these findings in populations of naturally infected cattle.

ABBREVIATIONS

OIE

Office Internationale des Épizooties

CF

Complement fixation

cELISA

Competitive ELISA

PPE

Percentage of parasitized erythrocytes

MBP

Maltose binding protein

MSP

Major surface protein

OD

Optical density

CI

Confidence interval

a.

Air-Tite Vet Premium blood-collecting needles, Air-tite Products Co, Virginia Beach, Va.

b.

Monoject No Additive sterile glass tubes, Sherwood Medical, St Louis, Mo.

c.

BD Vacutainer, Beckton Dickinson Vacutainer Systems, Franklin Lakes, NJ.

d.

Hema 3 staining system, Fisher Scientific, Pittsburgh, Pa.

e.

Microhematocrit capillary tubes, Chase Scientific Glass Inc, Rockwood, Tenn.

f.

Adams microhematocrit centrifuge, Model CT 2900, Clay Adams Inc, New York, NY.

g.

Anaplasma Antibody Test Kit, cELISA, VMRD Inc, Pullman, Wash.

h.

Iowa State University Dairy Breeding Research facility, Ankeny, Iowa.

i.

Kline Farms, Colo, Iowa.

j.

Microsoft Excel, Microsoft Corp, Redmond, Wash.

k.

JMP, version 5.1.2, SAS Institute Inc, Cary, NC.

References

  • 1

    Uilenberg G. International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health. Vet Parasitol 1995;57:1941.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2

    Dumler JS, Barbet AF, Bekker CPJ, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001;51:21452165.

    • Search Google Scholar
    • Export Citation
  • 3

    Kocan KM, de laFuente J, Guglielmone AA, et al. Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbiol Rev 2003;16:698712.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4

    Office International des Épizooties (OIE) Web site. Terrestrial Animal Health Code. Bovine anaplasmosis. Chapter 2.3.7. Available at: www.oie.int/eng/normes/mcode/code2006_back/ en_chapitre_2.3.7.htm. Accessed Mar 27, 2007.

    • Search Google Scholar
    • Export Citation
  • 5

    Kuttler KL, Simpson JE. Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves. Am J Vet Res 1978;39:347349.

    • Search Google Scholar
    • Export Citation
  • 6

    Stewart CG, Immelman A, Grimbeek P, et al. The use of a short and long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves. J S Afr Vet Assoc 1979;50:8385.

    • Search Google Scholar
    • Export Citation
  • 7

    Eriks IS, Palmer GH, McGuire TC, et al. Detection and quantitation of Anaplasma marginale in carrier cattle by using a nucleic acid probe. J Clin Microbiol 1989;27:279284.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8

    Reeves JD, Swift BL. Iatrogenic transmission of Anaplasma marginale in beef cattle. Vet Med Small Anim Clin 1977;72:911912.

  • 9

    Futse JE, Ueti MW, Knowles DP, et al. Transmission of Anaplasma marginale by Boophilus microplus: retention of vector competence in the absence of vector-pathogen interaction. J Clin Microbiol 2003;41:38293834.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Torioni de Echaide S, Knowles DP, McGuire TC, et al. Detection of cattle naturally infected with Anaplasma marginale by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant major surface protein 5. J Clin Microbiol 1998;36:777782.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    Bradway DS, Torioni deEchaide S, Knowles DP, et al. Sensitivity and specificity of the complement fixation test for detection of cattle persistently infected with Anaplasma marginale. J Vet Diagn Invest 2001;13:7981.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    Office International des Épizooties (OIE) Web site. Manual of standards for diagnostic tests and vaccines. Chapter 2.3.7. 5th ed. 2004. Available at: www.oie.int/eng/normes/mmanual/ a_00058. Accessed Oct 26, 2006.

    • Search Google Scholar
    • Export Citation
  • 13

    Veterinary Medical Research & Development (VMRD) Web site. Anaplasma antibody test kit, cELISA. Available at: www.vmrd. com/docs/tk/Anaplasma/Anaplasma_2_and_5-plate_circular_060505.pdf. Accessed Mar 27, 2007.

    • Search Google Scholar
    • Export Citation
  • 14

    Knowles DP, Torioni deEchaide S, Palmer GH, et al. Antibody against an Anaplasma marginale MSP5 epitope common to tick and erythrocyte stages identified persistently infected cattle. J Clin Microbiol 1996;34:22252230.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15

    Coetzee JF, Apley MD, Kocan KM, et al. Comparison of three oxytetracycline regimens for the treatment of persistent Anaplasma marginale infections in beef cattle. Vet Parasitol 2005;127:6173.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16

    Blouin EF, Barbet AF, Jooyoung Yi, et al.Establishment and characterization of an Oklahoma isolate of Anaplasma marginale in cultured Ixodes scapularis cells. Vet Parasitol 2000;87:301313.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    Blouin EF, Kocan KM, de laFuente J, et al. Effect of tetracycline on development of Anaplasma marginale in cultured Ixodes scapularis cells. Vet Parasitol 2002;107:115126.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    Martin WH, Richie WN. A microtiter technique for the complement fixation test for anaplasmosis. Proc Annu Meet U S Anim Health Assoc 1973;77:582592.

    • Search Google Scholar
    • Export Citation
  • 19

    USDA. A microtiter technique for the complement fixation test for anaplasmosis. Beltsville, Md: USDA, APHIS, Veterinary Services, 1974.

  • 20

    Thompson JR, Kersting KW, Wass WM, et al. Splenectomy in cattle via transthoracic approach. Am J Vet Res 1992;53:143144.

  • 21

    Agresti A, Coull BA. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 1998;52:119126.

  • 22

    Le CT. Probability and probability models. In:Introductory biostatistics. Hoboken, NJ: Wiley-Interscience, 2003;118119.

  • 23

    Dohoo I, Martin W, Stryhn H. Screening and diagnostic tests. In:Veterinary epidemiologic research. Charlottetown, PE, Canada: AVC Inc, 2003;9192.

    • Search Google Scholar
    • Export Citation
  • 24

    Morris DD. Normal values for erythron data in ruminants and the horse. In:Smith BP, ed.Large animal internal medicine. 2nd ed. St Louis: Mosby-Year Book Inc, 1996;1996

    • Search Google Scholar
    • Export Citation
  • 25

    Goff WL, Stiller D, Roeder RA, et al. Comparison of a DNA probe, complement-fixation and indirect immunofluorescence tests for diagnosing Anaplasma marginale in suspected carrier cattle. Vet Microbiol 1990;24:381390.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    Jones EW, Brock WE. Bovine anaplasmosis: its diagnosis, treatment, and control. J Am Vet Med Assoc 1966;149:16241633.

  • 27

    Jones EW, Kliewer IO, Norman BB, et al. Anaplasma marginale infection in young and aged cattle. Am J Vet Res 1968;29:535544.

  • 28

    Potgieter FT, Stoltsz WH. Anaplasmosis. In:Coetzer JAW, Tustin RC, ed.Infectious diseases of livestock. 2nd ed. Cape Town, South Africa: Oxford University Press, 2004:594610.

    • Search Google Scholar
    • Export Citation
  • 29

    Gale KR, Leatch G, DeVos AJ, et al. Anaplasma marginale: effect of challenge of cattle with varying doses of infected erythrocytes. Int J Parasitol 1996;26:14171420.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30

    Visser ES, McGuire TC, Palmer GH, et al. The Anaplasma marginale msp5 gene encodes a 19-kilodalton protein conserved in all recognized Anaplasma species. Infect Immun 1992;60:51395144.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Dreher UM, Hofmann-Lehmann R, Meli ML, et al. Seroprevalence of anaplasmosis among cattle in Switzerland in 1998 and 2003: no evidence of an emerging disease. Vet Microbiol 2005;107:7179.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    Munodzana D, McElwain TF, Knowles DP, et al. Conformational dependence of Anaplasma marginale major surface protein 5 surface-exposed B-cell epitopes. Infect Immun 1998;66:26192624.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33

    Hofmann-Lehmann R, Meli ML, Dreher UM, et al. Concurrent infections with vector-borne pathogens associated with fatal hemolytic anemia in a cattle herd in Switzerland. J Clin Microbiol 2004;42:37753780.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34

    Lin Q, Rikihisa Y, Feleks, et al.Anaplasma phagocytophilum has a functional msp2 gene that is distinct from p44. Infect Immun 2004;72:38833889.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35

    de la Fuente J, Lew A, Lutz H, et al. Genetic diversity of Anaplasma species major surface proteins and implications for anaplasmosis serodiagnosis and vaccine development. Anim Health Res Rev 2005;6:7589.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    Alderink FJ, Dietrick RA. Economic and epidemiological implications of anaplasmosis in Texas cattle herds. Proc Annu Meet U S Anim Health Assoc 1982;86:6675.

    • Search Google Scholar
    • Export Citation
  • 37

    de la Fuente J, Van DenBussche RA, Kocan KM. Molecular phylogeny and biogeography of North American isolates of Anaplasma marginale (Rickettsiaceae: Ehrlichieae). Vet Parasitol 2001;97:6576.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    de la Fuente J, Blouin EF, Kocan KM. Infection of ticks with the intracellular rickettsia, Anaplasma marginale excludes infection with other genotypes. Clin Diagn Lab Immunol 2003;10:182184.

    • Search Google Scholar
    • Export Citation
  • 39

    Kocan KM, de laFuente J, Blouin EF, et al. Anaplasma marginale (Rickettsiales: Anaplasmataceae): recent advances in defining host-pathogen adaptations of a tick-borne rickettsia. Parasitology 2004;129 (suppl):S285S300.

    • Crossref
    • Search Google Scholar
    • Export Citation

Contributor Notes

Drs. Coetzee and Apley's present address is Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506-5606.

Supported in part by the Alberta Beef Producers, Alberta Cattle Feeders Association, Alberta Livestock Industry Development Fund, Merial Canada Incorporated, Norbrook Laboratories Limited, and the Oklahoma Agricultural Experiment Station (project No. 1669). Dr. Kocan was supported by the Walter R. Sitlington Endowed Chair for Food Animal Research. Dr. Coetzee was supported by the Lloyd Endowed Professorship.

The authors thank Dr. Doug Ensley for technical assistance during the animal phase of the study; Drs. Jo Fisher, Karl Kersting, and Jim Thompson for surgical assistance; and Erin Rienstra, Joy Yoshioka, and Dollie Clawson for technical laboratory assistance.

Address correspondence to Dr. Coetzee.
  • Figure 1—

    Mean and 95% CI values for sensitivity of a cELISA (black squares) and a CF test (white diamonds) and the PPE (black triangles) and PCV (crosses) in 40 beef steers after inoculation with 2.6 × 109 Anaplasma marginale–infected erythrocytes. Day of inoculation was designated as day 0.

  • 1

    Uilenberg G. International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health. Vet Parasitol 1995;57:1941.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2

    Dumler JS, Barbet AF, Bekker CPJ, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001;51:21452165.

    • Search Google Scholar
    • Export Citation
  • 3

    Kocan KM, de laFuente J, Guglielmone AA, et al. Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbiol Rev 2003;16:698712.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4

    Office International des Épizooties (OIE) Web site. Terrestrial Animal Health Code. Bovine anaplasmosis. Chapter 2.3.7. Available at: www.oie.int/eng/normes/mcode/code2006_back/ en_chapitre_2.3.7.htm. Accessed Mar 27, 2007.

    • Search Google Scholar
    • Export Citation
  • 5

    Kuttler KL, Simpson JE. Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves. Am J Vet Res 1978;39:347349.

    • Search Google Scholar
    • Export Citation
  • 6

    Stewart CG, Immelman A, Grimbeek P, et al. The use of a short and long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves. J S Afr Vet Assoc 1979;50:8385.

    • Search Google Scholar
    • Export Citation
  • 7

    Eriks IS, Palmer GH, McGuire TC, et al. Detection and quantitation of Anaplasma marginale in carrier cattle by using a nucleic acid probe. J Clin Microbiol 1989;27:279284.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8

    Reeves JD, Swift BL. Iatrogenic transmission of Anaplasma marginale in beef cattle. Vet Med Small Anim Clin 1977;72:911912.

  • 9

    Futse JE, Ueti MW, Knowles DP, et al. Transmission of Anaplasma marginale by Boophilus microplus: retention of vector competence in the absence of vector-pathogen interaction. J Clin Microbiol 2003;41:38293834.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Torioni de Echaide S, Knowles DP, McGuire TC, et al. Detection of cattle naturally infected with Anaplasma marginale by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant major surface protein 5. J Clin Microbiol 1998;36:777782.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    Bradway DS, Torioni deEchaide S, Knowles DP, et al. Sensitivity and specificity of the complement fixation test for detection of cattle persistently infected with Anaplasma marginale. J Vet Diagn Invest 2001;13:7981.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    Office International des Épizooties (OIE) Web site. Manual of standards for diagnostic tests and vaccines. Chapter 2.3.7. 5th ed. 2004. Available at: www.oie.int/eng/normes/mmanual/ a_00058. Accessed Oct 26, 2006.

    • Search Google Scholar
    • Export Citation
  • 13

    Veterinary Medical Research & Development (VMRD) Web site. Anaplasma antibody test kit, cELISA. Available at: www.vmrd. com/docs/tk/Anaplasma/Anaplasma_2_and_5-plate_circular_060505.pdf. Accessed Mar 27, 2007.

    • Search Google Scholar
    • Export Citation
  • 14

    Knowles DP, Torioni deEchaide S, Palmer GH, et al. Antibody against an Anaplasma marginale MSP5 epitope common to tick and erythrocyte stages identified persistently infected cattle. J Clin Microbiol 1996;34:22252230.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15

    Coetzee JF, Apley MD, Kocan KM, et al. Comparison of three oxytetracycline regimens for the treatment of persistent Anaplasma marginale infections in beef cattle. Vet Parasitol 2005;127:6173.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16

    Blouin EF, Barbet AF, Jooyoung Yi, et al.Establishment and characterization of an Oklahoma isolate of Anaplasma marginale in cultured Ixodes scapularis cells. Vet Parasitol 2000;87:301313.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    Blouin EF, Kocan KM, de laFuente J, et al. Effect of tetracycline on development of Anaplasma marginale in cultured Ixodes scapularis cells. Vet Parasitol 2002;107:115126.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    Martin WH, Richie WN. A microtiter technique for the complement fixation test for anaplasmosis. Proc Annu Meet U S Anim Health Assoc 1973;77:582592.

    • Search Google Scholar
    • Export Citation
  • 19

    USDA. A microtiter technique for the complement fixation test for anaplasmosis. Beltsville, Md: USDA, APHIS, Veterinary Services, 1974.

  • 20

    Thompson JR, Kersting KW, Wass WM, et al. Splenectomy in cattle via transthoracic approach. Am J Vet Res 1992;53:143144.

  • 21

    Agresti A, Coull BA. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 1998;52:119126.

  • 22

    Le CT. Probability and probability models. In:Introductory biostatistics. Hoboken, NJ: Wiley-Interscience, 2003;118119.

  • 23

    Dohoo I, Martin W, Stryhn H. Screening and diagnostic tests. In:Veterinary epidemiologic research. Charlottetown, PE, Canada: AVC Inc, 2003;9192.

    • Search Google Scholar
    • Export Citation
  • 24

    Morris DD. Normal values for erythron data in ruminants and the horse. In:Smith BP, ed.Large animal internal medicine. 2nd ed. St Louis: Mosby-Year Book Inc, 1996;1996

    • Search Google Scholar
    • Export Citation
  • 25

    Goff WL, Stiller D, Roeder RA, et al. Comparison of a DNA probe, complement-fixation and indirect immunofluorescence tests for diagnosing Anaplasma marginale in suspected carrier cattle. Vet Microbiol 1990;24:381390.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    Jones EW, Brock WE. Bovine anaplasmosis: its diagnosis, treatment, and control. J Am Vet Med Assoc 1966;149:16241633.

  • 27

    Jones EW, Kliewer IO, Norman BB, et al. Anaplasma marginale infection in young and aged cattle. Am J Vet Res 1968;29:535544.

  • 28

    Potgieter FT, Stoltsz WH. Anaplasmosis. In:Coetzer JAW, Tustin RC, ed.Infectious diseases of livestock. 2nd ed. Cape Town, South Africa: Oxford University Press, 2004:594610.

    • Search Google Scholar
    • Export Citation
  • 29

    Gale KR, Leatch G, DeVos AJ, et al. Anaplasma marginale: effect of challenge of cattle with varying doses of infected erythrocytes. Int J Parasitol 1996;26:14171420.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30

    Visser ES, McGuire TC, Palmer GH, et al. The Anaplasma marginale msp5 gene encodes a 19-kilodalton protein conserved in all recognized Anaplasma species. Infect Immun 1992;60:51395144.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Dreher UM, Hofmann-Lehmann R, Meli ML, et al. Seroprevalence of anaplasmosis among cattle in Switzerland in 1998 and 2003: no evidence of an emerging disease. Vet Microbiol 2005;107:7179.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    Munodzana D, McElwain TF, Knowles DP, et al. Conformational dependence of Anaplasma marginale major surface protein 5 surface-exposed B-cell epitopes. Infect Immun 1998;66:26192624.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33

    Hofmann-Lehmann R, Meli ML, Dreher UM, et al. Concurrent infections with vector-borne pathogens associated with fatal hemolytic anemia in a cattle herd in Switzerland. J Clin Microbiol 2004;42:37753780.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34

    Lin Q, Rikihisa Y, Feleks, et al.Anaplasma phagocytophilum has a functional msp2 gene that is distinct from p44. Infect Immun 2004;72:38833889.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35

    de la Fuente J, Lew A, Lutz H, et al. Genetic diversity of Anaplasma species major surface proteins and implications for anaplasmosis serodiagnosis and vaccine development. Anim Health Res Rev 2005;6:7589.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    Alderink FJ, Dietrick RA. Economic and epidemiological implications of anaplasmosis in Texas cattle herds. Proc Annu Meet U S Anim Health Assoc 1982;86:6675.

    • Search Google Scholar
    • Export Citation
  • 37

    de la Fuente J, Van DenBussche RA, Kocan KM. Molecular phylogeny and biogeography of North American isolates of Anaplasma marginale (Rickettsiaceae: Ehrlichieae). Vet Parasitol 2001;97:6576.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    de la Fuente J, Blouin EF, Kocan KM. Infection of ticks with the intracellular rickettsia, Anaplasma marginale excludes infection with other genotypes. Clin Diagn Lab Immunol 2003;10:182184.

    • Search Google Scholar
    • Export Citation
  • 39

    Kocan KM, de laFuente J, Blouin EF, et al. Anaplasma marginale (Rickettsiales: Anaplasmataceae): recent advances in defining host-pathogen adaptations of a tick-borne rickettsia. Parasitology 2004;129 (suppl):S285S300.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement